Details of the Drug
General Information of Drug (ID: DM72AT8)
| Drug Name |
Proxyfan
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Proxyfan; proxifan; 3-(1H-imidazol-4-yl)propylphenylmethyl ether; 1H-Imidazole, 5-[3-(phenylmethoxy)propyl]-; AC1O4XL1; CHEMBL19173; GTPL1255; SCHEMBL4072620; SCHEMBL15929504; BDBM22915; CHEBI:93359; WNWALBVQAAIULR-UHFFFAOYSA-N; 4-(3-Benzyloxypropyl)-1H-imidazole; ZINC13813304; 5-[3-(benzyloxy)propyl]-1H-imidazole; 5-(3-phenylmethoxypropyl)-1H-imidazole; NCGC00159580-01; 4-[3-(phenylmethoxy)propyl]-3H-imidazole
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 216.28 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References


